C-type natriuretic peptide is a potent stimulator of cyclic GMP production in cultured mouse astrocytes

J Neurochem. 1992 Aug;59(2):762-4. doi: 10.1111/j.1471-4159.1992.tb09435.x.

Abstract

The effect of C-type natriuretic peptide (CNP), a novel member of the natriuretic peptide family, on cyclic GMP (cGMP) generation was studied in primary cultures of mouse astrocytes. CNP stimulated cGMP production by mouse astrocytes in a dose-dependent fashion, with an EC50 of 32 nM and a maximal stimulatory concentration of greater than 1 microM, which induced a rise of cGMP level from a baseline of 1.0 +/- 0.1 pmol/mg of protein to 196.2 +/- 22.0 pmol/mg of protein. Compared with our previously reported atrial and brain natriuretic peptide-induced cGMP responses, CNP had a lower EC50 and was 10-20 times more efficacious in its maximal effect on cGMP stimulation. These data lend support to the concept of a significant role of CNP in neuromodulation/neurotransmission.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / cytology*
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Cells, Cultured
  • Cyclic GMP / metabolism*
  • Dose-Response Relationship, Drug
  • Mice
  • Natriuretic Peptide, C-Type
  • Nerve Tissue Proteins / pharmacology*

Substances

  • Nerve Tissue Proteins
  • Natriuretic Peptide, C-Type
  • Cyclic GMP